As the FTSE 100 and FTSE 250 indices face downward pressure due to weak trade data from China, investors are closely monitoring the impact on UK markets. In such a challenging environment, identifying stocks trading below their estimated value can offer potential opportunities for those looking to navigate these uncertain times.
Name
Current Price
Fair Value (Est)
Discount (Est)
XP Power (LSE:XPP)
£12.30
£22.38
45%
Tekmar Group (AIM:TGP)
£0.0975
£0.17
44%
Pan African Resources (LSE:PAF)
£1.44
£2.71
46.9%
PageGroup (LSE:PAGE)
£2.012
£3.56
43.6%
Motorpoint Group (LSE:MOTR)
£1.38
£2.71
49.1%
M&C Saatchi (AIM:SAA)
£1.30
£2.48
47.5%
GB Group (LSE:GBG)
£2.38
£4.23
43.7%
CAB Payments Holdings (LSE:CABP)
£0.70
£1.31
46.4%
Barratt Redrow (LSE:BTRW)
£3.932
£7.24
45.7%
Atalaya Mining Copper (LSE:ATYM)
£10.38
£19.46
46.7%
Let’s review some notable picks from our screened stocks.
Overview: NIOX Group Plc focuses on designing, developing, and commercializing medical devices for asthma diagnosis, monitoring, and management globally with a market cap of £283.33 million.
Operations: The company generates revenue primarily from its NIOX® segment, which reported £46 million.
Estimated Discount To Fair Value: 27.2%
NIOX Group is currently trading at £0.68, under its estimated future cash flow value of £0.93, indicating potential undervaluation. The stock is priced 27.2% below its fair value estimate with analysts expecting a price rise of 23.5%. Earnings are projected to grow significantly at 35.2% per year, outpacing the UK market’s growth rate of 14.2%, despite revenue growth being moderate at 6.8% annually and profit margins having declined from last year.
AIM:NIOX Discounted Cash Flow as at Jan 2026
Overview: Man Group Limited is a publicly owned investment manager with a market cap of £2.90 billion, focusing on providing diverse investment solutions.
Operations: The company’s revenue segment includes an Investment Management Business generating $1.31 billion.
Estimated Discount To Fair Value: 42.5%
Man Group is trading at £2.6, significantly below its estimated future cash flow value of £4.52, suggesting it may be undervalued. The stock is valued 42.5% below fair value estimates with earnings expected to grow significantly at 32.7% annually, surpassing the UK market’s growth rate of 14.2%. However, profit margins have decreased from last year and the dividend yield of 4.8% lacks sufficient earnings coverage, which could be a concern for investors seeking income stability.
LSE:EMG Discounted Cash Flow as at Jan 2026
Overview: Zotefoams plc, along with its subsidiaries, is involved in the manufacturing, distribution, and sale of polyolefin foams across the United Kingdom, Europe, North America, and other international markets with a market cap of £200.26 million.
Operations: The company’s revenue segments include Segment Adjustment at £153.34 million and Mucell Extrusion LLC (MEL) at £0.82 million.
Estimated Discount To Fair Value: 15.8%
Zotefoams is trading at £4.11, slightly below its estimated future cash flow value of £4.88, indicating it may be undervalued based on cash flows. Earnings are forecast to grow significantly at 49.2% annually, outpacing the UK market’s growth rate of 14.2%. However, profit margins have decreased from last year and recent executive changes could impact strategic direction. The company’s revenue guidance for 2025 exceeds expectations with a projected increase to £158.5 million from £147.8 million in 2024.
LSE:ZTF Discounted Cash Flow as at Jan 2026
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include AIM:NIOX LSE:EMG and LSE:ZTF.
This article was originally published by Simply Wall St.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com